Stay updated on Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial

Sign up to get notified when there's something new on the Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A site-wide banner announces an NIH terminology transition, saying “Super Intelligence” is being used in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-26T13:45:09.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer's site revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-19T13:48:00.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page remains a 403 Forbidden error page, while the footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T14:34:40.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error with a minimal header and a Home link, replacing the previous detailed study content and sections.
    Difference
    21%
    Check dated 2026-09-21T20:40:06.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.6.6 replaces the previous v3.6.5 on the page, indicating a small update to the documentation. It does not alter study content or page functionality.
    Difference
    0.0%
    Check dated 2026-08-31T18:21:11.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page now includes an additional funding identifier indicating a U.S. NIH grant/contract for the study in 2016.
    Difference
    0.0%
    Check dated 2026-08-24T19:15:48.000Z thumbnail image

Stay in the know with updates to Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.